{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:01:24Z","timestamp":1790834484226,"version":"4.1.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI22\/00446"],"award-info":[{"award-number":["PI22\/00446"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP21\/00020"],"award-info":[{"award-number":["CP21\/00020"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["IHMC22-00032"],"award-info":[{"award-number":["IHMC22-00032"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["INT20\/00079"],"award-info":[{"award-number":["INT20\/00079"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["INT23\/00017"],"award-info":[{"award-number":["INT23\/00017"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Radiol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Metformin is one of the most widely used drugs to control diabetes type 2. However, there is no indication of pausing metformin treatment before an\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET scan. The aim of this study is to evaluate if metformin, in both patients and mice, can alter brain\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG uptake.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      <jats:italic>In vivo<\/jats:italic>\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET scans were carried out in male mice. Animals were treated with saline or metformin (300\u2005mg\/kg) 10\u2005min before\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG or chronically (3 weeks) in drinking water. Separately, patients with non-pathological\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG brain scans were distributed into two groups: metformin-treated (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200912) and control patients (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200927). PET images were structurally normalized to brain templates, corrected to whole-brain activity, and compared using SPM12.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In mice, acute treatment induced a significant hypermetabolism in several brain regions including hippocampus (1.07\u2009\u00b1\u20090.07 vs 0.94\u2009\u00b1\u20090.08;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0002) and thalamus (1.17\u2009\u00b1\u20090.08 vs 1.00\u2009\u00b1\u20090.08;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0002). Chronic treatment increased tracer uptake only in cortical regions. Similarly, treated patients showed hypermetabolism in the temporal lobe (1.03\u2009\u00b1\u20090.04 vs 0.97\u2009\u00b1\u20090.04;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&amp;lt;\u20090.0001) and white matter and lower uptake in frontal cortical regions (1.24\u2009\u00b1\u20090.04 vs 1.28\u2009\u00b1\u20090.06;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0165). Linear regression to HbA1c showed a negative correlation to\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG uptake in frontal and parietal cortical subregions, but no correlation to temporal lobe uptake.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>\n                      Our results show that metformin treatment might modify\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG uptake in temporal lobe structures. On the other hand, lower uptake in frontal cortex might be attributable to the diabetic condition. Thus, new studies modifying the treatment regimen in diabetic patients prior to performing an\n                      <jats:sup>18<\/jats:sup>\n                      F-FDG PET are warranted.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fradi.2026.1917175","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:42:40Z","timestamp":1790833360000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of metformin treatment on brain 18F-FDG uptake: a translational study"],"prefix":"10.3389","volume":"6","author":[{"given":"Rub\u00e9n","family":"Fern\u00e1ndez de la Rosa","sequence":"first","affiliation":[{"name":"Cartograf\u00eda Cerebral, Hospital Cl\u00ednico San Carlos, IdISSC","place":["Madrid, Spain"]},{"name":"Cartograf\u00eda Cerebral, Instituto Pluridisciplinar, Universidad Complutense de Madrid","place":["Madrid, Spain"]},{"name":"BioImaC, Universidad Complutense de Madrid","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Cuesta Domingo","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Hospital Cl\u00ednico San Carlos, IdISSC","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Nespral","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Hospital Cl\u00ednico San Carlos, IdISSC","place":["Madrid, Spain"]},{"name":"Nuclear Medicine Department, Hospital Puerta de Hierro","place":["Majadahonda,, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Marcos-Mac\u00edas","sequence":"additional","affiliation":[{"name":"Cartograf\u00eda Cerebral, Hospital Cl\u00ednico San Carlos, IdISSC","place":["Madrid, Spain"]},{"name":"Cartograf\u00eda Cerebral, Instituto Pluridisciplinar, Universidad Complutense de Madrid","place":["Madrid, Spain"]},{"name":"Departamento de Fisiolog\u00eda, Facultad de Medicina, Universidad Complutense de Madrid","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Vaillant","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Hospital Cl\u00ednico San Carlos, IdISSC","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Cartograf\u00eda Cerebral, Hospital Cl\u00ednico San Carlos, IdISSC","place":["Madrid, Spain"]},{"name":"Cartograf\u00eda Cerebral, Instituto Pluridisciplinar, Universidad Complutense de Madrid","place":["Madrid, Spain"]},{"name":"Departamento de Farmacolog\u00eda, Facultad de Farmacia, Universidad Complutense de Madrid","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Pozo","sequence":"additional","affiliation":[{"name":"Cartograf\u00eda Cerebral, Hospital Cl\u00ednico San Carlos, IdISSC","place":["Madrid, Spain"]},{"name":"Cartograf\u00eda Cerebral, Instituto Pluridisciplinar, Universidad Complutense de Madrid","place":["Madrid, Spain"]},{"name":"Departamento de Fisiolog\u00eda, Facultad de Medicina, Universidad Complutense de Madrid","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi A.","family":"Matias-Guiu","sequence":"additional","affiliation":[{"name":"Neurology Department, Hospital Cl\u00ednico San Carlos, IdISSC","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Nieves","family":"Cabrera-Martin","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, Hospital Cl\u00ednico San Carlos, IdISSC","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Brackhan","sequence":"additional","affiliation":[{"name":"Cartograf\u00eda Cerebral, Hospital Cl\u00ednico San Carlos, IdISSC","place":["Madrid, Spain"]},{"name":"Cartograf\u00eda Cerebral, Instituto Pluridisciplinar, Universidad Complutense de Madrid","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Bascu\u00f1ana","sequence":"additional","affiliation":[{"name":"Cartograf\u00eda Cerebral, Hospital Cl\u00ednico San Carlos, IdISSC","place":["Madrid, Spain"]},{"name":"Cartograf\u00eda Cerebral, Instituto Pluridisciplinar, Universidad Complutense de Madrid","place":["Madrid, Spain"]},{"name":"Nuclear Medicine Department, Hospital Cl\u00ednico San Carlos, IdISSC","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/dme.12467","article-title":"Diabetes and dementia in older people: a best clinical practice statement by a multidisciplinary national expert working group","volume":"31","author":"Sinclair","year":"2014","journal-title":"Diabet Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2S","DOI":"10.2967\/jnumed.121.263194","article-title":"(18)F-FDG PET imaging in neurodegenerative dementing disorders: insights into subtype classification, emerging disease categories, and mixed dementia with copathologies","volume":"63","author":"Minoshima","year":"2022","journal-title":"J Nucl Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1148\/rg.343135065","article-title":"Brain PET in suspected dementia: patterns of altered FDG metabolism","volume":"34","author":"Brown","year":"2014","journal-title":"Radiographics"},{"key":"B4","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American diabetes association (ADA) and the European association for the study of diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin\u2013mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and molecular mechanisms of metformin action","volume":"42","author":"LaMoia","year":"2021","journal-title":"Endocr Rev"},{"key":"B7","doi-asserted-by":"publisher","first-page":"44121","DOI":"10.1074\/jbc.M112.361386","article-title":"Metformin regulates glucose transporter 4 (GLUT4) translocation through AMP-activated protein kinase (AMPK)-mediated cbl\/CAP signaling in 3T3-L1 preadipocyte cells","volume":"287","author":"Lee","year":"2012","journal-title":"J Biol Chem"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","article-title":"The mechanisms of action of metformin","volume":"60","author":"Rena","year":"2017","journal-title":"Diabetologia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/RLU.0b013e318217399e","article-title":"Increased F-18 FDG intestinal uptake in diabetic patients on metformin: a matched case-control analysis","volume":"36","author":"Bybel","year":"2011","journal-title":"Clin Nucl Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s00259-007-0563-6","article-title":"High and typical 18F-FDG bowel uptake in patients treated with metformin","volume":"35","author":"Gontier","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s12149-016-1106-7","article-title":"Metformin discontinuation less than 72\u2005h is suboptimal for F-18 FDG PET\/CT interpretation of the bowel","volume":"30","author":"Lee","year":"2016","journal-title":"Ann Nucl Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2967\/jnumed.112.106666","article-title":"Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice","volume":"54","author":"Massollo","year":"2013","journal-title":"J Nucl Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.2214\/AJR.10.4663","article-title":"Impact of medication discontinuation on increased intestinal FDG accumulation in diabetic patients treated with metformin","volume":"195","author":"Oh","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00259-009-1330-7","article-title":"Clearance of the high intestinal (18)F-FDG uptake associated with metformin after stopping the drug","volume":"37","author":"Ozulker","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B15","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/s1734-1140(10)70357-1","article-title":"Quantification of metformin by the HPLC method in brain regions, cerebrospinal fluid and plasma of rats treated with lipopolysaccharide","volume":"62","author":"Labuzek","year":"2010","journal-title":"Pharmacol Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"694326","DOI":"10.1155\/2014\/694326","article-title":"Effects of metformin on the cerebral metabolic changes in type 2 diabetic patients","author":"Huang","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/cells14141064","article-title":"Neuroprotective effects of metformin through the modulation of neuroinflammation and oxidative stress","volume":"14","author":"Reed","year":"2025","journal-title":"Cells"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1007\/s00259-018-4254-2","article-title":"Obligatory role of endoplasmic reticulum in brain FDG uptake","volume":"46","author":"Cossu","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"B19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.neuroimage.2007.06.032","article-title":"A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator","volume":"38","author":"Mirrione","year":"2007","journal-title":"Neuroimage"},{"key":"B20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.endinu.2018.08.004","article-title":"Spanish diabetes society (SED) recommendations for the pharmacologic treatment of hyperglycemia in type 2 diabetes: 2018 update","volume":"65","author":"Gomez-Peralta","year":"2018","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.rceng.2020.06.009","article-title":"Medical treatment of type 2 diabetes mellitus: recommendations of the diabetes, obesity and nutrition group of the Spanish society of internal medicine","volume":"221","author":"Carrasco-Sanchez","year":"2021","journal-title":"Rev Clin Esp (Barc)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.1038\/s41598-021-81349-7","article-title":"Inhibition of mitochondrial function by metformin increases glucose uptake, glycolysis and GDF-15 release from intestinal cells","volume":"11","author":"Yang","year":"2021","journal-title":"Sci Rep"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1038\/s42255-026-01530-y","article-title":"Metformin inhibits mitochondrial complex I in intestinal epithelium to promote glycaemic control","volume":"8","author":"Sebo","year":"2026","journal-title":"Nat Metab"},{"key":"B24","doi-asserted-by":"publisher","first-page":"8126","DOI":"10.1038\/s41467-025-63279-4","article-title":"Metformin alters mitochondria-related metabolism and enhances human oligodendrocyte function","volume":"16","author":"Kazakou","year":"2025","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.neuroimage.2015.10.073","article-title":"Resting-state functional MRI and [18F]-FDG PET demonstrate differences in neuronal activity between commonly used mouse strains","volume":"125","author":"Shah","year":"2016","journal-title":"Neuroimage"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s11307-019-01314-9","article-title":"Anesthesia and preconditioning induced changes in mouse brain [(18)F] FDG uptake and kinetics","volume":"21","author":"Bascu\u00f1ana","year":"2019","journal-title":"Mol Imaging Biol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e0260482","DOI":"10.1371\/journal.pone.0260482","article-title":"Choice of anesthesia and data analysis method strongly increases sensitivity of 18F-FDG PET imaging during experimental epileptogenesis","volume":"16","author":"Jahreis","year":"2021","journal-title":"PLoS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e35752","DOI":"10.1016\/j.heliyon.2024.e35752","article-title":"Effects of chronic treatment with metformin on brain glucose hypometabolism and central insulin actions in transgenic mice with tauopathy","volume":"10","author":"Hurtado-Carneiro","year":"2024","journal-title":"Heliyon"},{"key":"B29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JAD-150493","article-title":"Metformin in amnestic mild cognitive impairment: results of a pilot randomized placebo controlled clinical trial","volume":"51","author":"Luchsinger","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"e70180","DOI":"10.1002\/hbm.70180","article-title":"Relationships between brain glucose metabolism patterns and impaired glycemic status: a systematic review of FDG-PET studies with a focus on Alzheimer's Disease","volume":"46","author":"Soltani","year":"2025","journal-title":"Hum Brain Mapp"},{"key":"B31","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2967\/jnumed.107.045385","article-title":"Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's Disease, and other dementias","volume":"49","author":"Mosconi","year":"2008","journal-title":"J Nucl Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.3233\/JAD-230640","article-title":"Type 2 diabetes and biomarkers of brain structure, perfusion, metabolism, and function in late mid-life: a multimodal discordant twin study","volume":"97","author":"Karayiannis","year":"2024","journal-title":"J Alzheimers Dis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2967\/jnumed.113.132647","article-title":"Diabetes and elevated hemoglobin A1c levels are associated with brain hypometabolism but not amyloid accumulation","volume":"55","author":"Roberts","year":"2014","journal-title":"J Nucl Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1210\/js.2019-00001","article-title":"Diabetes mellitus-related fractional glucose uptake in men and women imaged with (18)F-FDG PET-CT","volume":"3","author":"Waqas","year":"2019","journal-title":"J Endocr Soc"},{"key":"B35","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s11307-025-02027-y","article-title":"PET imaging of diabetes-induced alterations in metabolism and immune activation","volume":"27","author":"Lynch","year":"2025","journal-title":"Mol Imaging Biol"}],"container-title":["Frontiers in Radiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fradi.2026.1917175\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:42:41Z","timestamp":1790833361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fradi.2026.1917175\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":35,"alternative-id":["10.3389\/fradi.2026.1917175"],"URL":"https:\/\/doi.org\/10.3389\/fradi.2026.1917175","relation":{},"ISSN":["2673-8740"],"issn-type":[{"value":"2673-8740","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"article-number":"1917175"}}